Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer
Completed · Phase 1/Phase 2
Conditions studied: Extensive-Stage Small-Cell Lung Cancer
In brief
The purpose of this study is to determine the maximum tolerated dose and assess the safety, tolerability and activity of carfilzomib given in combination with carboplatin and etoposide as initial therapy for patients with extensive-stage small-cell lung cancer (ES SCLC).
Key facts
- Study ID
- NCT01987232
- Run by
- Amgen
- People needed
- 32
- Starts
- 2013-11-05
- Expected to finish
- 2017-05-04
- Last updated by the study team
- 2017-08-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yale University, Yale Cancer Center — New Haven, Connecticut, United States
- UF Health Davis Cancer Pavilion and Shands Med Plaza — Gainesville, Florida, United States
- Goshen Center for Cancer Care — Goshen, Indiana, United States
- Horizon Oncology Research, Inc. — Lafayette, Indiana, United States
- Indiana University Health Ball Memorial Hospital — Muncie, Indiana, United States
- Baptist Health Lexington Clinical Research Center — Lexington, Kentucky, United States
- Frederick Memorial Hospital — Frederick, Maryland, United States
- John Theurer Cancer Center at Hackensack UMC — Hackensack, New Jersey, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- Wake Forest Baptist Health — Winston-Salem, North Carolina, United States
- The University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- Juravinski Cancer Centre — Hamilton, Ontario, Canada
- Regional Budgetary Healthcare Institution "Kursk Regional Clinical Oncology Dispensary" — Kislino, Kursk Oblast, Russia
- State budgetary healthcare institution of Arkhangelsk Region "Arkhangelsk Clinical Oncological Dispensary" — Arkhangelsk, Russia
- Federal State Budgetary Scientific Institution "N.N. Blokhin Russian Cancer Research Center" — Moscow, Russia
- State Budgetary Educational Inslitution of Higher Professional Education "First St. Petersburg I.P.Pavlov State Medical University" — Saint Petersburg, Russia
- State Budgetary Healthcare Institution of Yaroslavl Region "Regional Clinical Oncological Hospital" — Yaroslavl, Russia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.